Professional Organization Meeting Summary Example

Professional Organization Meeting Summary Example Professional Organization Meeting Summary – Coursework Example Summary of the Houston Association of Nurse Practitioner (HANP) Meeting The Houston Association of Nurse Practitioners (HANP) meeting was convened todiscuss the effect of a once weekly therapy on A1C and weight over three years. The venue of the meeting was at Maggianos Little Italy and it was sponsored by AztraZaneca. It was scheduled to run from 6 pm to 8: 30 pm. From 6pm to 7pm, all participants were required to register and also interact with other participants. During this networking time, I was able to make three new friends. Two of them had been previous students while one was a current student. The speaker presentation was designed to run between 7pm to 8 pm. It also included a Q & A section. This presentation mainly covered the BYDUREON drug. BYDUREON is basically an injectable medicine used to treat type 2 diabetes by controlling the blood sugar level. Thus, BYDUREON aids a patient’s pancreas to efficiently produce the required insulin. The drug tends to increase the risk of thyroid c cell tumors in patients. Therefore, patients have to be counseled and informed about the symptoms and risk of thyroid tumors. Additionally, patients with a family or personal history of thyroid cancer or multiple endocrine neoplasia type 2 should not be given or should not use the drug. Although studies carried out on animals prove that the drug causes thyroid tumors, it is still unknown if it will cause thyroid tumors in human beings. This is mainly because high doses are used in animal tests. Thus, it is advisable to administer the drug to a patient only when the benefits outweigh the risks. The warnings and precautions mainly state that the drug should not be administered to patients with renal impairment and gastrointestinal disease. Also, the drug tends to cause serious injection site reactions. Furthermore, the drug causes some adverse reactions such as diarrhea, vomiting, nausea and injection site pruritus. Moreover, the drug interacts adversely with warfar in. The drug is not recommended to be used on pediatric patients, and pregnant and nursing women. After the end of the presentation and Q & A section, other business announcements were handled between 8 pm to 8:30pm. It was at this juncture that scholarships were awarded to two NPs and one DNP before the meeting was declared over.